chr11-7001199-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_013249.4(ZNF214):āc.484T>Cā(p.Phe162Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000255 in 1,613,102 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_013249.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF214 | NM_013249.4 | c.484T>C | p.Phe162Leu | missense_variant | 3/3 | ENST00000278314.5 | NP_037381.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF214 | ENST00000278314.5 | c.484T>C | p.Phe162Leu | missense_variant | 3/3 | 1 | NM_013249.4 | ENSP00000278314.4 | ||
ZNF214 | ENST00000536068.5 | c.484T>C | p.Phe162Leu | missense_variant | 4/4 | 1 | ENSP00000445373.1 |
Frequencies
GnomAD3 genomes AF: 0.000178 AC: 27AN: 151802Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000104 AC: 26AN: 251028Hom.: 0 AF XY: 0.0000958 AC XY: 13AN XY: 135690
GnomAD4 exome AF: 0.000263 AC: 385AN: 1461182Hom.: 0 Cov.: 76 AF XY: 0.000250 AC XY: 182AN XY: 726904
GnomAD4 genome AF: 0.000178 AC: 27AN: 151920Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74282
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2023 | The c.484T>C (p.F162L) alteration is located in exon 3 (coding exon 2) of the ZNF214 gene. This alteration results from a T to C substitution at nucleotide position 484, causing the phenylalanine (F) at amino acid position 162 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at